IO Biotech (IOBT) Competitors

IO Biotech logo
$0.92 -0.02 (-2.63%)
Closing price 02/12/2025 04:00 PM Eastern
Extended Trading
$0.92 +0.00 (+0.08%)
As of 05:28 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IOBT vs. CCCC, CRDF, ALMS, OGI, LFCR, CGEN, LRMR, AMRN, CTNM, and VIRI

Should you be buying IO Biotech stock or one of its competitors? The main competitors of IO Biotech include C4 Therapeutics (CCCC), Cardiff Oncology (CRDF), Alumis (ALMS), Organigram (OGI), Lifecore Biomedical (LFCR), Compugen (CGEN), Larimar Therapeutics (LRMR), Amarin (AMRN), Contineum Therapeutics (CTNM), and Virios Therapeutics (VIRI). These companies are all part of the "pharmaceutical products" industry.

IO Biotech vs.

IO Biotech (NASDAQ:IOBT) and C4 Therapeutics (NASDAQ:CCCC) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, institutional ownership, dividends, media sentiment, valuation, analyst recommendations, profitability, earnings and risk.

IO Biotech currently has a consensus price target of $9.33, indicating a potential upside of 919.70%. C4 Therapeutics has a consensus price target of $11.60, indicating a potential upside of 251.52%. Given IO Biotech's stronger consensus rating and higher probable upside, research analysts clearly believe IO Biotech is more favorable than C4 Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IO Biotech
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
C4 Therapeutics
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60

C4 Therapeutics received 5 more outperform votes than IO Biotech when rated by MarketBeat users. However, 91.67% of users gave IO Biotech an outperform vote while only 39.13% of users gave C4 Therapeutics an outperform vote.

CompanyUnderperformOutperform
IO BiotechOutperform Votes
22
91.67%
Underperform Votes
2
8.33%
C4 TherapeuticsOutperform Votes
27
39.13%
Underperform Votes
42
60.87%

IO Biotech has a net margin of 0.00% compared to C4 Therapeutics' net margin of -313.35%. C4 Therapeutics' return on equity of -42.45% beat IO Biotech's return on equity.

Company Net Margins Return on Equity Return on Assets
IO BiotechN/A -86.56% -75.24%
C4 Therapeutics -313.35%-42.45%-27.55%

In the previous week, C4 Therapeutics had 2 more articles in the media than IO Biotech. MarketBeat recorded 3 mentions for C4 Therapeutics and 1 mentions for IO Biotech. IO Biotech's average media sentiment score of 1.43 beat C4 Therapeutics' score of 0.93 indicating that IO Biotech is being referred to more favorably in the media.

Company Overall Sentiment
IO Biotech Positive
C4 Therapeutics Positive

IO Biotech has a beta of 0.24, meaning that its share price is 76% less volatile than the S&P 500. Comparatively, C4 Therapeutics has a beta of 2.95, meaning that its share price is 195% more volatile than the S&P 500.

IO Biotech has higher earnings, but lower revenue than C4 Therapeutics. C4 Therapeutics is trading at a lower price-to-earnings ratio than IO Biotech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IO BiotechN/AN/A-$86.08M-$1.37-0.67
C4 Therapeutics$33.67M6.92-$132.49M-$1.70-1.94

54.8% of IO Biotech shares are held by institutional investors. Comparatively, 78.8% of C4 Therapeutics shares are held by institutional investors. 2.3% of IO Biotech shares are held by company insiders. Comparatively, 8.6% of C4 Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

IO Biotech and C4 Therapeutics tied by winning 8 of the 16 factors compared between the two stocks.

Get IO Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for IOBT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IOBT vs. The Competition

MetricIO BiotechPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$60.30M$6.89B$5.66B$9.04B
Dividend YieldN/A2.90%5.31%4.00%
P/E Ratio-0.679.6390.3619.28
Price / SalesN/A312.201,035.7479.82
Price / CashN/A75.4646.0938.87
Price / Book0.455.535.135.00
Net Income-$86.08M$123.50M$113.24M$222.75M
7 Day Performance-3.55%-4.00%-0.99%-0.57%
1 Month Performance5.09%-1.51%4.19%3.00%
1 Year Performance-45.84%2.27%21.68%17.85%

IO Biotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IOBT
IO Biotech
3.9111 of 5 stars
$0.92
-2.6%
$9.33
+919.7%
-45.8%$63.90MN/A0.0030Short Interest ↓
Positive News
Gap Down
CCCC
C4 Therapeutics
2.8664 of 5 stars
$3.37
-5.1%
$11.60
+244.2%
-51.2%$237.89M$20.76M-1.98150Upcoming Earnings
Short Interest ↓
News Coverage
CRDF
Cardiff Oncology
2.2675 of 5 stars
$4.58
+1.8%
$10.33
+125.6%
+138.5%$234.18M$490,000.00-4.8720Short Interest ↑
ALMS
Alumis
N/A$4.82
-15.0%
$26.57
+451.3%
N/A$227.60MN/A0.00N/A
OGI
Organigram
0.6195 of 5 stars
$1.73
+3.0%
N/A-36.9%$218.26M$117.47M-4.55860Earnings Report
LFCR
Lifecore Biomedical
2.7317 of 5 stars
$5.87
-0.7%
$8.00
+36.3%
-31.8%$217.37M$128.26M-10.48690Gap Down
CGEN
Compugen
2.0147 of 5 stars
$2.42
-5.8%
$4.00
+65.3%
-6.0%$215.96M$33.46M121.0070
LRMR
Larimar Therapeutics
2.0723 of 5 stars
$3.37
-2.6%
$20.13
+497.2%
-58.7%$215.04MN/A-2.9330
AMRN
Amarin
0.3964 of 5 stars
$0.52
-3.3%
N/A-53.7%$214.95M$306.91M-5.82360Analyst Upgrade
News Coverage
Positive News
Gap Down
CTNM
Contineum Therapeutics
2.8845 of 5 stars
$8.25
-1.9%
$29.25
+254.5%
N/A$212.67M$50M0.0031Short Interest ↓
Gap Down
VIRI
Virios Therapeutics
0.1517 of 5 stars
$10.74
-9.1%
$3.00
-72.1%
+1,675.0%$206.83MN/A-39.785Gap Up

Related Companies and Tools


This page (NASDAQ:IOBT) was last updated on 2/13/2025 by MarketBeat.com Staff
From Our Partners